Annual CFI
-$93.89 M
-$37.98 M-67.94%
31 December 2023
Summary:
Cytek Biosciences annual cash flow from investing activities is currently -$93.89 million, with the most recent change of -$37.98 million (-67.94%) on 31 December 2023. During the last 3 years, it has fallen by -$92.35 million (-5969.42%). CTKB annual CFI is now -9549.95% below its all-time high of -$973.00 thousand, reached on 31 December 2019.CTKB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$15.81 M
-$17.83 M-881.85%
30 September 2024
Summary:
Cytek Biosciences quarterly cash flow from investing activities is currently -$15.81 million, with the most recent change of -$17.83 million (-881.85%) on 30 September 2024. Over the past year, it has dropped by -$58.93 million (-136.66%). CTKB quarterly CFI is now -136.66% below its all-time high of $43.12 million, reached on 30 September 2023.CTKB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$9.53 M
-$58.93 M-86.09%
30 September 2024
Summary:
Cytek Biosciences TTM cash flow from investing activities is currently $9.53 million, with the most recent change of -$58.93 million (-86.09%) on 30 September 2024. Over the past year, it has increased by +$183.55 million (+105.47%). CTKB TTM CFI is now -86.24% below its all-time high of $69.23 million, reached on 31 March 2024.CTKB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -67.9% | -136.7% | +105.5% |
| 3 y3 years | -5969.4% | -1108.6% | +428.4% |
| 5 y5 years | - | - | - |
CTKB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5969.4% | at low | -136.7% | +90.6% | -86.2% | +104.3% |
| 5 y | 5 years | -9550.0% | at low | -136.7% | +90.6% | -86.2% | +104.3% |
| alltime | all time | -9550.0% | at low | -136.7% | +90.6% | -86.2% | +104.3% |
Cytek Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.81 M(-881.8%) | $9.53 M(-86.1%) |
| June 2024 | - | $2.02 M(-135.1%) | $68.46 M(-1.1%) |
| Mar 2024 | - | -$5.75 M(-119.8%) | $69.23 M(-173.7%) |
| Dec 2023 | -$93.89 M(+67.9%) | $29.07 M(-32.6%) | -$93.89 M(-46.0%) |
| Sept 2023 | - | $43.12 M(+1445.7%) | -$174.02 M(-20.3%) |
| June 2023 | - | $2.79 M(-101.7%) | -$218.30 M(-2.5%) |
| Mar 2023 | - | -$168.87 M(+230.7%) | -$224.00 M(+300.7%) |
| Dec 2022 | -$55.91 M | -$51.06 M(+4340.3%) | -$55.91 M(+141.6%) |
| Sept 2022 | - | -$1.15 M(-60.5%) | -$23.14 M(-0.7%) |
| June 2022 | - | -$2.92 M(+273.7%) | -$23.30 M(+7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$780.00 K(-95.7%) | -$21.64 M(+3.1%) |
| Dec 2021 | -$20.99 M(+1257.0%) | -$18.30 M(+1298.8%) | -$20.99 M(+623.9%) |
| Sept 2021 | - | -$1.31 M(+4.6%) | -$2.90 M(+40.4%) |
| June 2021 | - | -$1.25 M(+806.5%) | -$2.07 M(+54.5%) |
| Mar 2021 | - | -$138.00 K(-32.0%) | -$1.34 M(-13.6%) |
| Dec 2020 | -$1.55 M(+59.0%) | -$203.00 K(-57.2%) | -$1.55 M(+15.1%) |
| Sept 2020 | - | -$474.00 K(-9.2%) | -$1.34 M(+54.5%) |
| June 2020 | - | -$522.00 K(+50.0%) | -$870.00 K(+150.0%) |
| Mar 2020 | - | -$348.00 K | -$348.00 K |
| Dec 2019 | -$973.00 K | - | - |
FAQ
- What is Cytek Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Cytek Biosciences?
- What is Cytek Biosciences annual CFI year-on-year change?
- What is Cytek Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cytek Biosciences?
- What is Cytek Biosciences quarterly CFI year-on-year change?
- What is Cytek Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cytek Biosciences?
- What is Cytek Biosciences TTM CFI year-on-year change?
What is Cytek Biosciences annual cash flow from investing activities?
The current annual CFI of CTKB is -$93.89 M
What is the all time high annual CFI for Cytek Biosciences?
Cytek Biosciences all-time high annual cash flow from investing activities is -$973.00 K
What is Cytek Biosciences annual CFI year-on-year change?
Over the past year, CTKB annual cash flow from investing activities has changed by -$37.98 M (-67.94%)
What is Cytek Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of CTKB is -$15.81 M
What is the all time high quarterly CFI for Cytek Biosciences?
Cytek Biosciences all-time high quarterly cash flow from investing activities is $43.12 M
What is Cytek Biosciences quarterly CFI year-on-year change?
Over the past year, CTKB quarterly cash flow from investing activities has changed by -$58.93 M (-136.66%)
What is Cytek Biosciences TTM cash flow from investing activities?
The current TTM CFI of CTKB is $9.53 M
What is the all time high TTM CFI for Cytek Biosciences?
Cytek Biosciences all-time high TTM cash flow from investing activities is $69.23 M
What is Cytek Biosciences TTM CFI year-on-year change?
Over the past year, CTKB TTM cash flow from investing activities has changed by +$183.55 M (+105.47%)